Straumann (SAUHF) Stock Price, News & Analysis

Company Overview

The Straumann Group is a global leader in implant dentistry and restorative solutions. Headquartered in Basel, Switzerland, the company develops, manufactures and distributes dental implants, prosthetic components and complementary biomaterials. Its portfolio spans a range of products designed to support oral surgery, restorative dentistry and digital workflows, including implant systems, surgical instruments, bone grafting materials and tissue regenerators.

Complementing its core implant business, Straumann has expanded into digital dentistry and orthodontics. The company offers intraoral scanners, 3D printing solutions and milling machines that enable dental professionals to design and fabricate crowns, bridges and custom abutments. Through its ClearCorrect subsidiary, Straumann provides clear aligner therapy, catering to both general practitioners and specialized orthodontists. Its products and services are utilized in more than 100 markets across Europe, North America, Latin America and Asia-Pacific.

Founded in 1954 as Institut Straumann in Waldenburg, Switzerland, the company has grown through sustained investment in research and development and strategic acquisitions. Key milestones include the introduction of the world’s first titanium screw-root dental implant and the integration of brands such as Neodent in Brazil and Anthogyr in France. These expansions have broadened Straumann’s geographic reach and diversified its offerings, reinforcing its position in both premium and emerging markets.

The company’s Executive Board is led by Chief Executive Officer Guillaume Daniellot, who oversees global operations and strategic initiatives. Reporting to an independent Board of Directors, the management team includes seasoned leaders in marketing, R&D, manufacturing and finance. Together, they guide Straumann’s mission to restore oral health and improve patients’ quality of life through innovative dental solutions.

Key Stats

• Today's Range: $115.15 to $118.60
• 50-Day Range: $113.10 to $137.93
• 52-Week Range: $101.15 to $172.00
• Volume: 277 shs
• Average Volume: 651 shs
• Market Capitalization: $18.87 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SAUHF Stock Analysis - Frequently Asked Questions

How have SAUHF shares performed this year?

Straumann's stock was trading at $122.5160 at the beginning of the year. Since then, SAUHF stock has decreased by 3.2% and is now trading at $118.60.

When did Straumann's stock split?

Straumann shares split on the morning of Wednesday, April 20th 2022.The 10-1 split was announced on Wednesday, April 20th 2022. The newly minted shares were distributed to shareholders after the market closes on Wednesday, April 20th 2022. An investor that had 100 shares of stock prior to the split would have 1,000 shares after the split.

How do I buy shares of Straumann?

Shares of SAUHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/10/2025
• Next Earnings (Estimated): 10/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SAUHF
• Previous Symbol: NASDAQ:SAUHF
• CIK: 1451279
• Web: www.straumann.com
• Phone: (161) 965-1111
• Fax: 41-61-965-1001
• Employees: 10,500
• Year Founded: 1954

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $2.43 billion
• Price / Sales: 7.76
• Cash Flow: $2.87 per share
• Price / Cash Flow: 41.32
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 159,100,000
• Free Float: N/A
• Market Cap: $18.87 billion
• Optionable: Not Optionable
• Beta: 1.35